Death by a Thousand Cuts -- Combining Kinase Inhibitors for Selective Target Inhibition and Rational Polypharmacology
I. R. Outhwaite, S. Singh, B.-T. Berger, S. Knapp, J. D. Chodera, M. A. Seeliger
This paper presents a method to improve kinase inhibitor selectivity by combining inhibitors with divergent off-target activities, validated using a NanoBRET assay.
bioRxiv · Jan 13, 2023Pharmacology & Toxicology